Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mapping public policy on genetics.

N E Weisfeld1

  • 1Medical Society of New Jersey, Lawrenceville, NJ 08649, USA.

Gene Therapy
|May 29, 2002
PubMed
Summary
This summary is machine-generated.

Advances in human genetics are shaping public policy. Key considerations include data privacy, cost-effectiveness, and potential impacts on insurance, employment, and legal contexts, guiding future genetic information governance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Whom to believe? A review of recent malpractice cases.

New Jersey medicine : the journal of the Medical Society of New Jersey·2005
Same author

Slow to pay. MSNJ's prospective-payment timeliness survey.

New Jersey medicine : the journal of the Medical Society of New Jersey·2001
Same author

Patients' bill of rights.

New Jersey medicine : the journal of the Medical Society of New Jersey·2001
Same author

Getting results. Physician advocacy in the age of managed care.

New Jersey medicine : the journal of the Medical Society of New Jersey·2001
Same author

A friend leaves for Washington.

New Jersey medicine : the journal of the Medical Society of New Jersey·2001
Same author

MSNJ launches enhanced HMO complaint system.

New Jersey medicine : the journal of the Medical Society of New Jersey·2001
Same journal

Improving the precision of AAV lung gene therapy for SP-B deficiency using computationally derived lung-specific promoters.

Gene therapy·2026
Same journal

Recent advancements in improving cross-species applicability of bioengineered AAV capsids.

Gene therapy·2026
Same journal

Assessment of F/HN-pseudotyped lentiviral vector following intravenous delivery to mice.

Gene therapy·2026
Same journal

Applications of genome editing technologies in the treatment of human diseases.

Gene therapy·2026
Same journal

High resolution ES-DMA quantifies AAV capsid DNA content by electrical mobility to mass correlation.

Gene therapy·2026
Same journal

AAV8-mediated mouse/human PROC expression rescues thrombophilia in hereditary protein C-deficient mice.

Gene therapy·2026
See all related articles

Area of Science:

  • Genetics and Public Policy
  • Bioethics
  • Health Law

Background:

  • Human genome mapping and genetic research advancements are driving the need for new public policies.
  • Existing public policy principles like privacy, cost-effectiveness, and anecdotal evidence influence genetic policy development.

Purpose of the Study:

  • To analyze the key factors influencing the development of public policies related to genetics.
  • To identify information and service areas impacted by genetic advances.
  • To anticipate likely government actions concerning genetic information and services.

Main Methods:

  • Review of current public policy principles.
  • Analysis of information and service areas affected by genetic advancements.
  • Projection of potential government interventions and policy actions.
Keywords:
Genetics and Reproduction

Related Experiment Videos

Main Results:

  • Policy development will be shaped by privacy, cost-effectiveness, and anecdotal evidence.
  • Affected areas include genetic discrimination, confidentiality, databanks, and legal testing.
  • Potential government actions include consent requirements, database licensing, and mandated insurance coverage for cost-effective services.

Conclusions:

  • Public policy must adapt to the rapid pace of genetic research and its applications.
  • Balancing individual privacy with public interest is crucial in genetic data governance.
  • Strategic investment in research, tailored treatments, and workforce training is recommended.